Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: A contributor to the beneficial effects of coffee on diabetes

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Ong, Khang Wei ^a   Hsu, Annie ^a   Tan, Benny Kwong Huat ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROGENIC ACID; GLUCOSE; GLUTAMINE; SMALL INTERFERING RNA; WORTMANNIN; (6 (4 (2 PIPERIDIN 1 YLETHOXY)PHENYL)) 3 PYRIDIN 4 YLPYRAZOLO(1,5 A)PYRIMIDINE; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; COFFEE; CONTROLLED STUDY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; MALE; MOUSE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; SOLEUS MUSCLE; ANIMAL; BLOOD; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; DIET RESTRICTION; DISEASE MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; CELL SURVIVAL; CHLOROGENIC ACID; COFFEE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FASTING; GENE SILENCING; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PYRAZOLES; PYRIMIDINES; SIGNAL TRANSDUCTION;

EID: 84857802931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032718     Document Type: Article

References (46)

1. Agardh EE, Carlsson S, Ahlbom A, Efendic S, Grill V, et al. (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. Journal of Internal Medicine 255: 645-652.
2. Lin WY, Xaiver Pi-Sunyer F, Chen CC, Davidson LE, Liu CS, et al. (2011) Coffee consumption is inversely associated with type 2 diabetes in Chinese. European Journal of Clinical Investigation 41: 659-666.
3. Pereira MA, Parker ED, Folsom AR, (2006) Coffee consumption and risk of type 2 diabetes mellitus: An 11-year prospective study of 28 812 postmenopausal women. Archives of Internal Medicine 166: 1311-1316.
4. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, et al. (2004) Coffee Consumption and Risk for Type 2 Diabetes Mellitus. Annals of Internal Medicine 140: 1-8+I17.
5. Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P, (2004) Coffee Consumption and Risk of Type 2 Diabetes Mellitus among Middle-aged Finnish Men and Women. Journal of the American Medical Association 291: 1213-1219.
6. Van Dam RM, (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Applied Physiology, Nutrition and Metabolism 33: 1269-1283.
7. Battram DS, Arthur R, Weekes A, Graham TE, (2006) The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. Journal of Nutrition 136: 1276-1280.
8. Robinson LE, Savani S, Battram DS, McLaren DH, Sathasivam P, et al. (2004) Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. Journal of Nutrition 134: 2528-2533.
9. Thong FSL, Derave W, Kiens B, Graham TE, Ursø B, et al. (2002) Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51: 583-590.
10. Petrie HJ, Chown SE, Belfie LM, Duncan AM, McLaren DH, et al. (2004) Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. American Journal of Clinical Nutrition 80: 22-28.
11. Battram DS, Graham TE, Dela F, (2007) Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline in humans. Journal of Physiology 583: 1069-1077.
12. Lee S, Hudson R, Kilpatrick K, Graham TE, Ross R, (2005) Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28: 566-572.
13. Keijzers GB, De Galan BE, Tack CJ, Smits P, (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25: 364-369.
14. Van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, et al. (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32: 1023-1025.
15. Arion WJ, Canfield WK, Ramos FC, Schindler PW, Burger HJ, et al. (1997) Chlorogenic acid and hydroxynitrobenzaldehyde: New inhibitors of hepatic glucose 6-phosphatase. Archives of Biochemistry and Biophysics 339: 315-322.
16. McCarty MF, (2005) A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Medical Hypotheses 64: 848-853.
17. Bassoli BK, Cassolla P, Borba-Murad GR, Constantin J, Salgueiro-Pagadigorria CL, et al. (2008) Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: Effects on hepatic glucose release and glycaemia. Cell Biochemistry and Function 26: 320-328.
18. Shearer J, Farah A, De Paulis T, Bracy DP, Pencek RR, et al. (2003) Quinides of Roasted Coffee Enhance Insulin Action in Conscious Rats. Journal of Nutrition 133: 3529-3532.
19. De Valk HW, (1999) Magnesium in diabetes mellitus. Netherlands Journal of Medicine 54: 139-146.
20. Clifford MN, (2000) Chlorogenic acids and other cinnamates- Nature, occurrence, dietary burden, absorption and metabolism. Journal of the Science of Food and Agriculture 80: 1033-1043.
21. Hemmerle H, Burger HJ, Below P, Schubert G, Rippel R, et al. (1997) Chlorogenic acid and synthetic chlorogenic acid derivatives: Novel inhibitors of hepatic glucose-6-phosphate translocase. Journal of Medicinal Chemistry 40: 137-145.
22. Prabhakar PK, Doble M, (2009) Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine 16: 1119-1126.
23. Liu IM, Hsu FL, Chen CF, Cheng JT, (2000) Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats. British Journal of Pharmacology 129: 631-636.
24. Klip A, Li G, Logan WJ, (1984) Role of calcium ions in insulin action on hexose transport in L6 muscle cells. The American journal of physiology 247: E297-304.
25. Mitsumoto Y, Klip A, (1992) Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. Journal of Biological Chemistry 267: 4957-4962.
26. Konrad D, Rudich A, Bilan PJ, Patel N, Richardson C, et al. (2005) Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. Diabetologia 48: 954-966.
27. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M, (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. Journal of Biological Chemistry 269: 3568-3573.
28. Lee M, Hwang JT, Lee HJ, Jung SN, Kang I, et al. (2003) AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. Journal of Biological Chemistry 278: 39653-39661.
29. Kim YD, Park KG, Lee YS, Park YY, Kim DK, et al. (2008) Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57: 306-314.
30. Mueckler M, (1994) Facilitative glucose transporters. European Journal of Biochemistry 219: 713-725.
31. Holmes BF, Kurth-Kraczek EJ, Winder WW, (1999) Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. Journal of Applied Physiology 87: 1990-1995.
32. Winder WW, Hardie DG, (1999) AMP-activated protein kinase, a metabolic master switch: Possible roles in Type 2 diabetes. American Journal of Physiology- Endocrinology and Metabolism 277: E1-E10.
33. Hardie DG, Hawley SA, (2001) AMP-activated protein kinase: the energy charge hypothesis revisited. Bioassays 23: 1112-1119.
34. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, et al. (2003) Complexes between the LKB1 tumor suppressor, STRADα/β and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade. Journal of Biology 2.
35. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, et al. (2005) Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2: 9-19.
36. Rathmann W, Giani G, Wild SH, Roglic G, Green A, et al. (2004) Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 [8] (multiple letter). Diabetes Care 27: 2568-2569.
37. Surya Prakash N, Combes MC, Somanna N, Lashermes P, (2002) AFLP analysis of introgression in coffee cultivars (Coffea arabica L.) derived from a natural interspecific hybrid. Euphytica 124: 265-271.
38. Van Dieren S, Uiterwaal CSPM, Van Der Schouw YT, Van Der ADL, Boer JMA, et al. (2009) Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 52: 2561-2569.
39. Kahn BB, Alquier T, Carling D, Hardie DG, (2005) AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 1: 15-25.
40. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW, (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48: 1667-1671.
41. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, et al. (2006) Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491. Journal of Biological Chemistry 281: 5335-5340.
42. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, et al. (2004) Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells. Journal of Biological Chemistry 279: 1304-1309.
43. Nagata D, Mogi M, Walsh K, (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. Journal of Biological Chemistry 278: 31000-31006.
44. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H, (2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochemical and Biophysical Research Communications 287: 562-567.
45. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, et al. (2005) AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Molecular Cell 18: 283-293.
46. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: A play in three akts. Genes and Development 13: 2905-2927.